CURRICULUM VITAE
August 28, 2015
Merab Lomia, M.D., Ph.D.
Address: 1, Field House
Close, Ascot, SL5 9LT,
Berkshire, UK
Citizenship:
1)
United Kingdom
2)
Georgia
Phone: +44751 6906500
Email: lomiamer@yahoo.com
Website: www.asthma.ge
Summary: 2 patents in the field of drug development, 29 years of experience in clinical and experimental
medicine and neurology, 17 years of experience in pharmacovigilance, 17 years of experience in clinical
trials
Education:
01.08.1979 – 01.08.1985: Medical Doctor’s Degree, Tbilisi State Medical University, Faculty of Internal
Medicine
01.08.1985 – 31.08.1986: Specialty training in Neurology, Department of Neurological Diseases, Central
University Hospital, Tbilisi, Georgia
01.11.1988 – 01.11.1991: Postgraduate Doctoral Study, Tbilisi State Medical University, and Beritashvili
Institute of Physiology
24.09.1993 – PhD Degree
Career and professional experience:
03.05.2011 – till now: Drug Safety Physician, Medical Reviewer, Eli Lilly Erl Wood Centre, Windlesham,
Surrey, UK
Providing medical technical expertise in evaluation of individual adverse events; supporting the case
management staff in ensuring appropriate follow-up; reviewing assessments of listedness based on global and
specific requirements and being accountable for the medical assessment of the information within the case
report; training and mentorship to Global Patient Safety case managers with respect to the medical aspects of
the management, pharmacovigilance expertise through surveillance teams meetings, discussion and training
programs; safety related training programs and presentations. Creation and implementation of Multi-tab
Access Program for proper listedness evaluation of Lilly and non-Lilly products and for fast access to other
frequently used websites, documents and programs.
04.05.2010 – 20.03.2011: Senior Clinical Safety Associate, ICON, Eastleigh, UK
Document and process Serious Adverse Event Reports, spontaneously reported adverse events, and other
medically related information per study specific procedures, provide input and review relevant safety tracking
systems, perform safety review of clinical data (case report forms) and patient labs, completion of quality
control feedbacks forms, attend sponsor and project team meetings and teleconferences. Clinical and postmarketing studies experience.
05.06.2008 – 19.02.2010: Clinical Safety Associate, Novartis Horsham Research Centre, Horsham, UK.
Responsible for the accurate data entry of Serious Adverse Events /Post Marketing Events and the evaluation
on non-expeditable reports within agreed timeframes, in compliance with IMS business rules, standard
operating procedures and regulatory requirements.
23.12. 2004 – 15.10.2007: Senior Medical Advisor, Pharmacovigilance Dept., Georgian Drug Agency,
Tbilisi, Georgia.
Responsible for the risk management and risk minimization plans, monitoring of spontaneous adverse events
registration system, medical and scientific review, analyzing and interpretation of AE reports and aggregate
1
data reviews. Registration, medical review and analyzing of positive side effects of drugs. Coordination of
SAE activities for assigned projects. See also ‘Pharmacovigilance experience’ on page 3.
10.11.1998 – 13.10.2007 (part-time): Medical Advisor, Chief Neurologist, “Rea” Medical Rehabilitation
Centre for Chronic Disorders, Tbilisi, Georgia. Implementation and monitoring of new methods of
pharmacotherapy of neurological and neurogenic disorders. Pharmacotherapy of bronchial asthma as
neurogenic inflammatory disorder. PI, clinical trials (see ‘Clinical trials’ on page 3). Daily clinical work with
patients, clinical rounds and consultations.
08.01.1997 – 22.12.2004 (till 12 October 1998 – part-time): Pharmacovigilance Specialist, National Drug
Monitoring Center of Pharmacovigilance, Tbilisi, Georgia. Implementation and monitoring of spontaneous
adverse events registration system, medical and scientific review, analyzing and interpretation of AE reports,
training of physicians and nurses concerning adverse event reporting. See also ‘Pharmacovigilance
experience’ on page 3.
02.10.1993 – 12.10.1998 - Research Scientist Doctor and Lecturer, Neurological Department, Scientific
Research Institute of Pediatrics, Tbilisi, Georgia.
Clinical research studies in child neurology. EEG-computer topography (brain-mapping) and clinical
observational study of antagonists of opiate analgetics for therapy of tics, Tourette syndrome and nocturnal
enuresis. Daily and on-duty clinical work with in- and out-patients. Taught post-graduate courses for
registrars and fellow physicians in neuropharmacology.
01.12.1991 – 01.10.1993 – Senior Medical Investigator, Neurological Department, Scientific Research
Institute of Pediatrics, Tbilisi, Georgia.
EEG-computer topography (brain-mapping), in children with neurological disorders. Daily and on-duty
clinical work with in- and out-patients.
01.11.1988 – 01.12.1991 – Postgraduate Doctoral Study (Doctoral fellowship), jointly in Neurological
Department, Tbilisi State Medical University, and in Department of Metabolic Maintenance of the Brain
Functions, I. Beritashvili Institute of Physiology, Georgian Academy of Sciences, Tbilisi, Georgia. Study
title: Experimental use of fluorochemical “artificial blood” in therapy of various experimental models of
acute cerebral ischemia. Models of brain ischemia in rabbits and rats.
31.08.1986 – 01.11.1988 - Neurologist, Senaki district Mendzhi State Hospital, Georgia.
Medical practice of wide range of out-patients with neurological disorders. Treatment of neurological
patients. Neurological consultations for non-neurological patients. Daily and on-duty clinical work.
01.08.1985 – 31.08.1986 – Specialty training in Neurology, Department of Neurological Diseases, Central
University Hospital, Tbilisi, Georgia.
Patents: In the field of drug development:
1) EU, USA (application):
WO 0066096, New Indication for Use of Antiepileptic Agents and Medicines.
http://www.wipo.int/pctdb/en/wo.jsp?wo=2000066096
2) Georgia:
P 2487, New indication for 5-carbamoyl-5H-dibenz(b,f)azepine, its derivatives and analogues
P 2612, New indication for use of antiepileptic agents and medicines
Awards:
Silver Sponsorship from European Respiratory Society (ERS) for the attendance at the European Respiratory
Society Annual Congress, 2006, Copenhagen, Denmark
Silver Sponsorship from ERS for the attendance at the European Respiratory Society Annual Congress, 2005,
Glasgow, UK
Award from the Soros Foundation for the participation in the Salzburg-Cornell Seminar in Neurology,
Salzburg, Austria, 1996, and for the Internship, C. Doppler Landesnervenklinik, Salzburg, Austria, 1999.
Knowledge of languages: Fluent in Georgian, English, Russian
2
IELTS (Academic level): Overall Band Score: 7. Listening: 7, Reading: 7, Writing: 6, Speaking: 7. Test
Report Form No: 06GE000097LOMM001A
Teaching and lecturing experience:
1997-2007: Lectures in pharmacovigilance for registrar physicians and pharmacists. Training of physicians in
hospitals and out-patients clinics (adverse events (AE) forms completion, etc).
1995-2007: Taught post-graduate courses for resident physicians, fellow physicians and nurses, during the
Georgian Diabetic Camp Summer sessions, Bakuriani, Georgia (Neurological complications of diabetes,
type1).
1993 – 1998: Taught Post-graduate courses for resident physicians, fellow physicians and nurses, Scientific
Research Institute of Pediatrics, Tbilisi, Georgia (Pharmacotherapeutic aspects of child neurology)
1989 – 1991: Seminars in neurology for medical students, Tbilisi State Medical Institute/University
Scientific Consultant of Doctoral Fellow (PhD Student):
1997 - 1999- Manana Pruidze, Beritashvili Institute of Physiology, Title of doctoral dissertation: “EEGactivity in adult patients with bronchial asthma” (1999).
Reviewer of medical journals:
Respiratory Medicine, http://www.sciencedirect.com/science/journal/09546111
The Journal of Neurology, Neurosurgery, and Psychiatry, http://jnnp.bmj.com
Pharmacovigilance experience:
-
-
risk assessment risk management, risk minimization plans, medical input into PSURs and
other periodic reports, ICRs and aggregate data review
medical and scientific expertise for regulatory documents
coordination of AE and SAE activities for assigned projects
adhering to current regulations and FDA, EMEA and ICH guidelines relating to ADR monitoring
AE and ADR reporting plans for National Drug Monitoring Center of Pharmacovigilance and
Georgian Drug Agency
management of case-handling process, medical and scientific analysis and review of AE reports
AE forms in hospitals and out-patients stations: instructions for the completion (CIOMS Form, etc.)
medical review of AE and SAE information received from research sites
preparing and submitting of expedited safety reports to pharmaceutical companies, ethic committees
and national regulatory authority (till 2004 - Pharmacological Committee of Georgia, Ministry of
Health)
SUSAR and annual reporting review for clinical trials
consulting of healthcare system authorities in pharmacovigilance
training of physicians and nurses concerning adverse event reporting
management of data entry into safety database, ARGUS, ARIS Global
generation of queries to sites for follow-up information for Georgian Drug Agency
presentations of AE reporting at hospital and pharmaceutical company meetings
Standard Operational Procedures (SOP) for Georgian Drug Agency
review of pharmacovigilance publications and information sources to keep updated on current
regulations
Therapeutic Area/Lab Experience:
Oncology - Phase III, IV, multi country
Diabetes - Phase III, IV, multi country
Bronchial Asthma, COPD - Phase III, IV, multi
country
Endocrinology - Phase III, IV, multi country
Neurology - Phase III, IV, multi country
Cardiology - Phase III, IV, multi country
Psychiatry - Phase III, IV, multi country
Transplantology - Phase III, IV, multi country
Urology - Phase III, IV, multi country
Infections - Phase III, IV, multi country
Viral Hepatitis - Phase III, IV, multi country
3
Clinical trials:
Links to registered clinical trials: http://www.clinicaltrials.gov/ct/search?term=Lomia&submit=Search
Research experience:
Until 2007 I worked with Z. Chapichadze, MD, PhD (Drug Agency, Ministry of Health, Tbilisi, Georgia), M.
Pruidze, MD, PhD (Centre of Chinese Medicine, Tbilisi, Georgia), and T. Tchelidze, MD (CRO “Evidence”,
Tbilisi,
Georgia),
and
other
members
of
the
scientific
group
“Neuroasthma”
(www.asthma.ge/neuroasthma.htm).
In 1993 we found that in patients with trigeminal neuralgia and bronchial asthma, carbamazepine and
valproates reduced the severity of asthma symptoms. Since 1994 we performed observational clinical studies
and double-blind placebo-controlled randomized trials concerning use of antiasthmatic drugs for treatment of
bronchial asthma. Our trials showed high antiasthmatic activity of antiepileptic drugs in adults and in children
with asthma. In collaboration with Prof. V. Maloletnev, MD, PhD (Department of Human Psychophysiology,
Beritashvili Institute of Physiology, Tbilisi, Georgia), we also investigated the frequency of EEG and
neurological signs in patients with asthma, and frequency of breath-holding spells in anamnesis of children
with asthma. In experimental studies we investigated the influence of antiepileptic drugs on
Herxheimer microshock and anaphylactic shock in Guinea pigs. We received the silver sponsorship for
presenting of our data in ERS Congresses from European Respiratory Society in 2004 and 2005.
Since 2004 I worked in Georgian Drug Agency as Pharmacovigilance Senior Consultant. In 1997 – 2004 I
worked as Senior Specialist in National Drug Monitoring Center of Pharmacovigilance, Tbilisi, Georgia, in
collaboration of Dr. Zaza Chapichadze, MD, PhD, and Prof. Nicholas Gongadze, MD, PhD. Refer to previous
section “Pharmacovigilance Experience”.
In 1998 - 1999 I worked in scientific cooperation with Prof. Sh. Bibileishvili, MD, PhD (Sarajishvili Institute
of Experimental and Clinical Neurology, Tbilisi, Georgia), and investigated the epidemiology, clinical signs
and the outcome in patients with ischemic stroke and sleep apnea.
In 1995 - 1997 in collaboration with Prof. N. Mitagvaria, PhD (Dept. of Metabolic Maintenance of the Brain
Functions, Beritashvili Institute of Physiology, Tbilisi, Georgia), I examined the surface tension of blood
during cerebral ischemia and discovered that blood surface tension was increased in patients with ischemic
stroke.
In 1994 - 1995 I worked in scientific collaboration with K. Gambashidze, MD, PhD (Department of
Pathophysiology, Tbilisi State Medical University), and researched rheological properties of blood, including
surface tension of blood, in rats with Walker carcinoma and in mice with Erlich carcinoma. We also
investigated the influence of non-ionogenic surfactants on blood rheology and on survivability of
experimental animals.
In 1993 - 1998 I worked in the Scientific Research Institute of Pediatrics (Tbilisi, Georgia) and researched
EEG-computer topography (brain-mapping) in children with tic hyperkinesia, Tourette syndrome and
nocturnal enuresis. We also use antagonists of opiate analgetics for therapy of tics, Tourette syndrome and
nocturnal enuresis, and performed observational studies in this direction. We established that naloxone can
reduce frequency and intensity of tics, and also can reduce the frequency of episodes of night enuresis. We
also found that EEG disturbances in these children are frequent, but non-specific.
1988 - 1993: My PhD thesis was related to experimental use of fluorochemical “artificial blood” in therapy of
experimental models of acute cerebral ishemia. Experimental studies were performed under supervision of
Prof. N. Mitagvaria, PhD (Department of Metabolic Maintenance of the Brain Functions, Beritashvili
Institute of Physiology, Tbilisi, Georgia), resulting in the possibility of clinical implementation of these
findings under supervision of Prof. A. Lachkepiani, MD, PhD (Neurological Dept, Tbilisi State
Medical Institute/University). We studied several models of ishemia in rabbits and rats and found that
fluorochemical blood substitutes improved rheological properties of blood, microcirculation and brain supply
with oxygen during brain ischemia. We supposed that it was possible to use fluorochemical blood substitutes
in wide range of urgent clinical conditions, in which mechanisms cerebral ischemia plays important role. We
4
were unable to continue these studies due to the collapse of the Soviet Union and, therefore, to the loss of
supply of necessary materials.
Computer skills: SPSS for Windows (statistical program), MS Word, Excel, PowerPoint, Adobe Photoshop,
web-design (www.asthma.ge )
Oral presentations at the international meetings: 15th Congress of European Respiratory Society,
Copenhagen, Denmark, 2005: see www.asthma.ge/trileptal.ppt , or http://www.erseducation.org/pages/default.aspx?id=335&idBrowse=13598&det=1
List of publications:
Book: Children with Disabilities: Educational, Psychological and Medical Aspects of Social Integration (in
Georgian, with co-authors). Tbilisi, 2002, 290p.
Dissertation: “Experimental use of perfluorochemical gas-carrying blood substitute during acute brain
ischemia” (in Georgian, Eng. abstr). Tbilisi, 1993, 254p. See # 25 in:
http://www.nplg.gov.ge/ec/en/dis/catalog.html?pft=biblio&from=21&rnum=10&udc=616.8
Articles in peer-review and international journals:
Lomia M. Bronchial asthma as neurogenic paroxysmal inflammatory disease: Do some antiepileptic drugs
have antiasthmatic properties? Medical Hypotheses, 2007, vol. 69, no. 4, pp. 858 – 859. http://www.medicalhypotheses.com/article/PIIS0306987707001454/abstract , or doi:10.1016/j.mehy.2007.02.004
Lomia M, Tchelidze T, Pruidze M. Bronchial asthma as neurogenic paroxysmal inflammatory disease: a
randomized trial with carbamazepine. Respir Med, 2006, vol.100, no.11, pp. 1988-1996.
http://www.resmedjournal.com/article/PIIS095461110600103X/abstract , or doi:10.1016/j.rmed.2006.02.018
Lomia M, Chapichadze Z, Pruidze M, Platonov P. Efficacy of monotherapy with carbamazepine
and valproic acid in patients with bronchial asthma: Is asthma a neurological disease? The Internet
Journal of Neurology, 2005, v.4, #1. http://ispub.com/IJN/4/1/6172
Articles in Georgian and Russian journals:
Chapichadze Z, Chelidze T, Lomia M. affective respiratory paroxysms in the anamnesis of children with
bronchial asthma (Eng. abstr.)[ in Russian]. Allergology and Immunology, vol. 7, № 5, 2006, pp. 610-611.
Lomia M. Effects of antiepileptic drugs on anaphylactic shock and on Herxheimer microshock in Guinea
pigs. Bull. Georg. Acad. Sci., 2006, vol.173, №3, pp. 605-607.
http://www.science.org.ge/moambe/173_3/Summuru_173-3.htm (Then find “Lomia”)
Lomia M, Ratiani R, Chelidze T. Severe persistent bronchial asthma: high efficacy of carbamazepine. Bull.
Georg. Acad. Sci, 172, №2, 2005. http://www.science.org.ge/moambe/New/pub15/172_2/172_2.htm#Lomia,
(Then find “Lomia”)
Lomia M. Bronchial asthma as neurogenic paroxysmal disease: high antiasthmatic efficacy of carbamazepine
in double-blind placebo-controlled trial. Bull. Georg. Acad. Sci, 169, №2, 2004.
http://www.science.org.ge/moambe/New/pub15/169_2/169_2.html (Then find “Lomia”)
Lomia M. EEG and neurological symptoms, learning disability and AD/HD in children with bronchial
asthma. Journal of Education and Rehabilitation for Children with Disabilities. 2002, no.1 (1), pp. 37-40.
Lomia M, Pruidze M. Correlation of EEG and clinical signs in patients with bronchial asthma. Messenger
Georg. Acad. Sci (Biol), 2000, 26 (4-6): 411-415.
Lomia M. EEG and neurological symptoms in adult patients with bronchial asthma. In: 2nd Convention of
Georgian Physiologists. Proceedings. Tbilisi, 2000, pp. 98-100.
Lomia M, Pruidze M, Kharatishvili I. Frequency of neurological symptoms and pathological reflexes in
bronchial asthma and their correlation with severity of disease. Georgian Medical News, 1997, no.11 (32),
pp.27-29.
5
Pruidze M, Lomia M, Kharatishvili I. Neurological symptoms in adults with bronchial asthma (Eng. abstr.)
[in Georgian]. Sakartvelos Sameditsino Moambe [Georgian Medical Messenger], 1997, no. 4, pp.23-26.
Lomia M, Pruidze M, Kharatishvili I. Neurological and EEG-computer topographic studies in adults with
bronchial asthma. Georgian Medical News, 1997, no.10 (31), pp.29-31.
Lomia M, Pruidze M, Kharatishvili I. Neurological symptoms and reflexes in children with bronchial
asthmatic attacks. Georgian Medical News, 1997, no. 6 (27), pp.34-35.
Lomia M, Daraselia M. The frequency of pediatric neurological pathology in Republic of Georgia [in
Georgian] (Eng. abstr., Rus. abstr.) Sakartvelos Sameditsino moambe [Georgian Medical Messenger], 1996,
no.3-4, pp. 67-70.
Lomia M, Mamisashvili V, Mchedlishvili N, Kumsishvili T. Influence of "artificial blood" on brain tissue
metabolic supply and basic microcirculatory mechanisms [in Georgian] (Eng. abstr., Rus. abstr). Sakartvelos
Pediatri [Pediatrist of Georgia], 1992, no.2, pp. 10-15.
Lomia M. The influence of fluorocarbon gas-carrying "artificial blood" on brain tissue pO2 in normal
conditions and during ischemia [in Georgian] (Eng. abstr., Rus abstr). Bull. Georg. Acad. Sci, 1991, vol. 141,
no.2, pp.413-416.
Lomia M, Cheishvili M. Use of oxygen-carrying "artificial blood" during brain ischemia (review) [in
Georgian]. Sakartvelos Sameditsino Moambe [Georgian Medical Messenger], 1991, no.5-6, pp.32-35.
Abstracts of international conferences:
Lomia M, Pruidze M, Chapichadze Z, T. Tchelidze T. Bronchial asthma as neurogenic inflammatory and
paroxysmal disease – efficacy of antiepileptic drug diphenine in asthma therapy. Abstracts of 16th Congress
of European Respiratory Society, Minich, Germany, 2006. Eur Respir J 2006; 28: Suppl. 50, 316s.
http://lrp.ersnet.org//abstract_print_06/files/152.pdf
Lomia M, Tchelidze T, Pruidze M. Efficacy of antiepileptic drugs diphenine and carbamazepine in
pharmacotherapy of children with bronchial asthma: is asthma a neurogenic inflammatory disease? Abstracts
of 16th Congress of European Respiratory Society, Minich, Germany, 2006. Eur Respir J 2006; 28: Suppl.
50, 204s. http://lrp.ersnet.org//abstract_print_06/files/107.pdf
Lomia M, Pruidze M, Chapichadze Z. Bronchial asthma as neurogenic paroxysmal inflammatory disease high efficacy of antiepileptic drug oxcarbazepine in asthma monotherapy. Abstracts of 15th Congress of
European Respiratory Society, Copenhagen, Denmark, 2005. Eur Respir J 2005; 26: Suppl. 49, 466s.
http://www.ers-education.org/events/international-congress/copenhagen-2005.aspx?idParent=13591
Lomia M, Pruidze M, Chapichadze Z. Bronchial asthma as neurogenic paroxysmal disease - high
effectiveness of carbamazepine in asthma monotherapy. Abstracts of 14th Congress of European Respiratory
Society, Glasgow, UK, 2004. Eur. Respir. J, 2004, vol. 24, suppl. 48, 221s. http://www.erseducation.org/events/international-congress/glasgow-2004.aspx?idParent=16821
Lomia M, Pruidze M, Chapichadze Z. Efficacy of monotherapy with anticonvulsive drugs topiramate and
carbamazepine in bronchial asthma: is asthma a neurological disease? Abstracts of 14th Congress of
European Respiratory Society, Glasgow, UK, 2004. Eur. Respir. J, 2004, vol. 24, suppl. 48, 130s.
http://www.ers-education.org/events/international-congress/glasgow-2004.aspx?idParent=16270
Bibileishvili E, Lomia M, Bibileishvili Sh. Sleep apnea and ischemic stroke. Abstracts of the 10th European
Stroke Conference. Lisbon, Portugal, May 16-19, 2001. Cerebrovasc Dis. 2001; 11 Suppl 4: 93.
http://www.archive.eurostroke.org/Lisbon/Li%20risk_etiology.asp (then find “Lomia”)
Bibileishvili E, Lomia M, Bibileishvili Sh. Sleep apnea as a riskfactor in the development of ischemic stroke.
11th meeting of the European Neurological Society. 21-25 April, 2001, Paris, France. Abstracts. J Neurol.
2001,
248.
Suppl
2:
126.
http://www.blackwell-synergy.com/doi/abs/10.1111/j.14681331.2004.00920.x?journalCode=ene
Shota Bibileishvili, Merab Lomia, Shota Bibileishvili. Desynchronosis of hemocoagulation an the
localization of the pathological focus in patients with ischemic stroke. Abstracts From the 6th International
6
Symposium on ASTT. Stroke 2000;31;2890. http://stroke.ahajournals.org/cgi/reprint/31/11/2881.pdf (then
find “Lomia”)
Eteri Bibileishvili, Merab Lomia, Eteri Bibileishvili. Relationship between a biorhythm hemostasis chance
and the character of vascular pathology in case of ischemic stroke. Abstracts From the 4th World Stroke
Congress. Stroke 2000;31;2801. http://stroke.ahajournals.org/cgi/reprint/31/11/2768.pdf (then find “Lomia”)
Lomia M, Pruidze M, Kharatishvili I. EEG-computer topography in adult patients with bronchial asthma. In:
Materials of Black Sea Countries 2nd International Conference “Advances of Clinical and Theoretical
Medicine and Biology.” Trabzon, Turkey, 2000.
Lomia M, Kharatishvili I. Effectiveness of naloxone in the treatment of nocturnal enuresis in children.
Proceedings of 4th EFNS Congress, Lisbon, Portugal, 07-11 September 1999. European Journal of Neurology
1999, vol.6, suppl.3, p. 44.
Lomia M, Daraselia M. Metoclopramide and naloxone in treatment of tics. Posters of 5th International
Congress of Parkinson’s Disease and Movement Disorders, NY, October 14-18, 1998. Movement Disorders,
1998, vol.13, suppl. 2, p. 203.
Kharatishvili I, Lomia M, Pruidze M. Frequency of neurological signs in adults with bronchial asthma.
Abstracts of “Interasma’97”, Annual Meeting Western Europe Chapter, Las Palmas, Canary Island, Spain,
December 3-5, 1997. Journal of Investigational Allergology and Clinical Immunology, 1997, no.5, p.543
Lomia M, Kharatishvili I, Pruidze M. Lack of correlation between frequency of neurological symptoms and
severity of bronchial asthma. Abstracts of “Interasma’97”, Annual Meeting Western Europe Chapter, Las
Palmas, Canary Island, Spain, December 3-5, 1997. Journal of Investigational Allergology and Clinical
Immunology, 1997, no.5, p.543
Lomia M. Increase of blood surface tension during acute ischemic stroke. Proceedings of EFNS Prague
Meeting, June 4-8, 1997. European Journal of Neurology, 1997, vol 4, suppl 1, p. S102.
Lomia M. Effectiveness of metoclopramide in treatment of tic hyperkinesia in children. Proceedings of
EFNS Prague Meeting, June 4-8, 1997. European Journal of Neurology, 1997, vol 4, suppl 1, p. S101-S102.
Lomia M, Mitagvaria N. Experimental use of perfluorochemical gas-carrying blood substitute during brain
ischemia. Proceedings of EFNS Prague Meeting, June 4-8, 1997. European Journal of Neurology, 1997, vol
4, suppl 1, p.S101
Lomia M, Kharatishvili I. EEG computer topography in children with tic hyperkinesia. In: The 4th
International Conference of Baltic Child Neurology Association (BCNA), Tartu, Estonia, May 25-28, 1997:
programme and abstracts. Tartu, 1997. p 59.
Lomia M.B. Effectiveness of opioid antagonists in the treatment of tic hyperkinesia and nocturnal enuresis in
children. Abstracts of symposia and free communications. 5th Meeting of ENS, 17-21 June, 1995, Munich,
Germany. Journal of Neurology, 1995, vol. 242, no.6, suppl.2, p. S61.
www.springerlink.com/index/Y35L117687712T12.pdf
Abstracts of Georgian conferences:
Lomia M, Chapichadze Z, Tchelidze T, Pruidze M. High efficacy of antiepileptic drug carbamazepine in
pharmacotherapy of bronchial asthma: Is bronchial asthma a neurogenic inflammatory disease? Abstracts of
1st International Congress of the Georgian Respiratory Association. Tbilisi, Georgia, May 31-June 2, 2007.
Georgian Respiratory Journal, 2007, 3: Suppl. 1, p. 99
Lomia M. Some features and problems of adequate neurological assistance for contingent of disable children
[in Georgian]. In: Inclusive and Special Education Problems in National Program of EFA of Georgia.
Materials of National Seminar, 25-29 November, Tbilisi 2002, pp. 46-49. UNESCO, Tbilisi, 2003.
Pruidze M, Lomia M, Mandzhgaladze N. Disturbances of brain bioelectric activity in patients with bronchial
asthma and their correlation with other asthmatic clinical symptoms [in Georgian]. In: Actual problems of
medicine. Materials of Conference, dedicated to memory of Simeon Kipshidze. Tbilisi 1997, pp. 35-38
7
Lomia M, Mandzhgaladze N, Pruidze M. Neurological investigations in children with bronchial asthma [in
Georgian]. In: Actual problems of medicine. Materials of Conference, dedicated to memory of Simeon
Kipshidze. Tbilisi, 1997, pp. 25-27
Lomia M. Experimental use of oxygen-carrying fluorocarbon blood substitute during brain ischemia,
provoked by head trauma [in Georgian]. In: Actual problems of military medicine. Materials of scientific
conference. Tbilisi, 1995, pp.114.
Lomia M.B. Influence of non-ionogenic surfactant "Proxanol P-268" on CBF and arterial pressure in normal
rats and in animals with acute brain ischemia [in Georgian]. In: Actual problems of military medicine.
Materials of scientific conference. Tbilisi, 1995, pp.25-27.
Gambashidze K, Lomia M, Khutsishvili G, Tsibadze A. Change of mechanical resistance of red blood cells
in rats during implanted Walker carcinoma after treatment by non-ionogenic surfactant "Proxanol P-268” and
alpha-tocoferol. In: Materials of Georgian Physiologists Conference, dedicated to 60th anniversary of
Georgian Physiological Society Foundation. Tbilisi, 1995, p.178.
Lomia M, Gambashidze K. Surface tension of blood and red blood cells' deformability in mice during
growth of implanted Erlich carcinoma. In: Materials of Georgian Physiologists Conference, dedicated to 60th
anniversary of Georgian Physiological Society Foundation. Tbilisi, 1995, p.93.
Lomia M.B. The influence of pyrogenicity of gas-carrying perfluorochemical blood substitute on oxygen
supply of brain tissue (Eng. abstr.) [in Georgian]. In: Actual Problems of Pediatrics. Issue of articles,
dedicated to 30th Anniversary of Georgian Pediatric Institutes Foundation. Tbilisi, 1991, pp.254-259.
Samushia O.S, Lomia M.B. Modern aspects of therapy of brain ischemia (Eng. abstr.). Proc. of 21st
Scientific Conference of Young Physicians. Telavi, 1991, pp.96-97.
Lomia M.B. Use of gas-carrying fluorocarbon "artificial blood” during cerebral ischemia and other vascular
diseases (Eng. abstr.). Proc. of 21st Scientific Conference of Young Physicians. Telavi, 1991, pp.96-97.
Lomia M.B. Use of fluorochemical "artificial blood” for the treatment of brain ischemia (Eng. abstr.). Proc.
of 20th Republican Scientific Conference of Young Physicians. Bakuriani, Tbilisi, 1991, pp.96-97.
Lomia M.B. Copper concentration in blood during infantile cerebral paralysis [in Russian]. In: Proc. of 47th
Conf. of Tbilisi State Medical Institute I.Takaishvili Medical Society. Tbilisi, 1984, pp.97-98.
You can find additional information and links to my published papers and Internet scientific publications on
my website: www.asthma.ge
8